2020
DOI: 10.1016/j.jiph.2019.09.014
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
14
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 33 publications
1
14
0
Order By: Relevance
“…These 23 studies were further reviewed, and five only were included in the meta-analysis; in the end, 14 studies with inappropriateness were included. [27][28][29][30][31][32][33][34][35][36][37][38][39][40] Therefore a total 32 studies were eventually included in the study; details of the study characteristics are provided in online supplemental table 1.…”
Section: Results and Findings General Characteristicsmentioning
confidence: 99%
“…These 23 studies were further reviewed, and five only were included in the meta-analysis; in the end, 14 studies with inappropriateness were included. [27][28][29][30][31][32][33][34][35][36][37][38][39][40] Therefore a total 32 studies were eventually included in the study; details of the study characteristics are provided in online supplemental table 1.…”
Section: Results and Findings General Characteristicsmentioning
confidence: 99%
“…However, it did not decrease the readmission rate [ 25 ]. Readmission for UTI patients was assessed in a retrospective chart review comparing outcomes between two different periods, and this intervention proved to be effective in reducing readmission rates [ 26 ]. Staphylococcal bloodstream infection was investigated in one particular study through conducting unsolicited standardised form-based ASP and resulted in a reduction in the 30-day readmission rate.…”
Section: Discussionmentioning
confidence: 99%
“…Numerous developed countries, including the United States, United Kingdom, Australia, and Canada, have implemented AMS programs successfully ( Seo et al, 2016 ; Charani et al, 2017 ; DiDiodato and McAthur, 2017 ; Rautemaa-Richardson et al, 2018 ; Cipko et al, 2020 ); however, its implementation in developing countries is challenging ( Hayat et al, 2020 ). It has been proven that pharmacist-driven AMS is beneficial in reducing the duration of antimicrobial treatment, shortening hospital stays, lowering patient mortality, optimizing antimicrobials use, and limiting the emergence of multidrug-resistant organisms ( Li et al, 2017 ; Parente and Morton, 2018 ; Wang et al, 2019 ; Sadyrbaeva-Dolgova et al, 2020 ; Takito et al, 2020 ). Therefore, the increased involvement of hospital pharmacists with AMS deserves more in-depth implementation and broader promotion.…”
Section: Discussionmentioning
confidence: 99%